Bitran, J D <br/><br/>
A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGB.  [electronic resource] 

 -  American journal of clinical oncology  Feb 1995 
 - 67-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199502000-00014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Small Cell--therapy<br/>Cisplatin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Interferon-gamma--therapeutic use<br/>Lung Neoplasms--therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Survival Analysis<br/>Treatment Outcome